Report cover image

Global Throat Cancer Therapeutics Market 2024-2028

Publisher TechNavio
Published Dec 15, 2023
Length 158 Pages
SKU # INF18402505

Description

Global Throat Cancer Therapeutics Market 2024-2028


The throat cancer therapeutics market is forecasted to grow by USD 2.33 bn during 2023-2028, accelerating at a CAGR of 7.51% during the forecast period. The report on the throat cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of throat cancer, the growing use of tobacco products, and increasing risk factors for throat cancer.

Technavio's throat cancer therapeutics market is segmented as below:

By Type

Pharyngeal cancer
Laryngeal cancer

By Distribution Channel

Offline
Online

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing strategic alliances of the vendors as one of the prime reasons driving the throat cancer therapeutics market growth during the next few years. Also, rising adoption of patient assistance programs and strong pipeline of throat cancer therapeutics will lead to sizable demand in the market.

The report on the throat cancer therapeutics market covers the following areas:

Throat cancer therapeutics market sizing
Throat cancer therapeutics market forecast
Throat cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading throat cancer therapeutics market vendors that include Adlai Nortye Ltd., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Clinigen Group Plc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Moderna Inc, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi SA. Also, the throat cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

158 Pages
    • Market overview
    • Market ecosystem
    • Market definition
    • Market segment analysis
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
    • Global throat cancer therapeutics market 2018 - 2022
    • Type Segment Analysis 2018 - 2022
    • Distribution Channel Segment Analysis 2018 - 2022
    • Geography Segment Analysis 2018 - 2022
    • Country Segment Analysis 2018 - 2022
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Type
    • Pharyngeal cancer - Market size and forecast 2023-2028
    • Laryngeal cancer - Market size and forecast 2023-2028
    • Market opportunity by Type
    • Market segments
    • Comparison by Distribution Channel
    • Offline - Market size and forecast 2023-2028
    • Online - Market size and forecast 2023-2028
    • Market opportunity by Distribution Channel
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2023-2028
    • Europe - Market size and forecast 2023-2028
    • Asia - Market size and forecast 2023-2028
    • Rest of World (ROW) - Market size and forecast 2023- 2028
    • US - Market size and forecast 2023-2028
    • India - Market size and forecast 2023-2028
    • Hungary - Market size and forecast 2023-2028
    • Canada - Market size and forecast 2023-2028
    • Poland - Market size and forecast 2023-2028
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market trends
    • Overview
    • Vendor landscape
    • Landscape disruption
    • Industry risks
    • Vendors covered
    • Market positioning of vendors
    • Adlai Nortye Ltd.
    • Amgen Inc.
    • AstraZeneca Plc
    • Bayer AG
    • Bristol Myers Squibb Co.
    • Celldex Therapeutics Inc.
    • Clinigen Group Plc
    • Eli Lilly and Co.
    • F. Hoffmann La Roche Ltd.
    • Merck KGaA
    • Moderna Inc
    • Novartis AG
    • Pfizer Inc.
    • Regeneron Pharmaceuticals Inc.
    • Sanofi SA
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us